Atrial Fibrillation (AF) is the most common arrhythmia (irregular heart rhythm disorder), which is having a huge and increasing burden on patients…

Jennifer Turgiss leads the behaviour science and analytics teams at Johnson & Johnson (J&J), applying her expertise in behavioural and social science to develop digital health behaviour change interventions. We spoke to Jennifer at this year’s eyeforpharma, Barcelona on her long-standing career in the Health and Wellness industry and scaling bespoke patient behaviour change programmes.

Prof Salles provided an update on the ongoing first-line follicular lymphoma (FL) studies, demonstrating how analysis of the GALLIUM study data regarding…

Cesar Sanz Rodriguez is Associate Vice President, Medical Affairs Lead Mid-Europe (MER), Eastern Europe, Middle East & Africa (EEMEA) Regions. He spoke to us about his progression into medical affairs from a clinical background, the changing role of medical affairs in the pharma industry, and the exciting advances currently taking place in cancer treatment.

Karsten Lollike is the Corporate Vice President and the Qualified Person Responsible for Pharmacovigilance (QPPV) of Global Safety at Novo Nordisk, a position he has held for 11 years. Dr. Lollike joined Novo Nordisk in 2000, working in Global Development in Haemostasis, after obtaining his medical degree and subsequently a PhD. We spoke to Dr. Lollike about his medical expertise and experience, his long-standing career at Novo Nordisk, and what working at the company means to him.

NephMadness, now in its 7th year, is a derivative of the annual USA collegiate basketball championships, colloquially known as March Madness.

Affecting up to 11.4% of the population worldwide, psoriasis is one of the most common chronic autoinflammatory diseases.

This review starts with an excellent description of the pathophysiology of bronchopulmonary dysplasia, which should be informative to physicians who will…